Pressreleases

Butterworth Laboratories Announces New Facility in Hampton, UK

UK contract analytical chemistry provider Butterworth Laboratories is delighted to announce it has secured a facility in Hampton, Middlesex.

Hierarchy For Capa Effectiveness

Have you ever reviewed an investigation report and wondered whether the proposed corrective and preventive action (CAPA) would be effective?

Sometimes, we shrug our shoulders and say, “At least they put something in place”. We all know that the FDA expects us to include an effectiveness check, but do we have enough guidance to make these checks meaningful? NSF suggests that you consider these three questions:
1. What will you measure?
2. When will you measure it?
3. What is your acceptance standard?

Upcoming Pharmaceutical Courses from NSF

Make sure you remember to take advantage of any discounts you could be entitled to! Get in touch if you're interested in bringing any of this training on-site.

Hospital-Acquired Pneumonia Prevention Market

Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global hospital-acquired pneumonia prevention market. The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The US$ 795 Mn market is likely to exhibit a CAGR of 4.7%, reaching a value in excess of US$ 1,100 Mn by the end of 2026.

Hospital-Acquired Pneumonia Prevention Market

Over an eight-year period of assessment 2018-2026, the global market for hospital-acquired pneumonia prevention is poised to witness moderate growth, according to a recent research report on the global hospital-acquired pneumonia prevention market. The report has been published by Persistence Market Research and is titled, “Hospital-Acquired Pneumonia Prevention Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026.” The US$ 795 Mn market is likely to exhibit a CAGR of 4.7%, reaching a value in excess of US$ 1,100 Mn by the end of 2026.

Meet SHL at BIO International Convention 2018

SHL Group, a world leader in device design and manufacturing, is proud to be participating in the 2018 BIO International Convention in Boston, Massachusetts from June 4-7.
SHL will be at Booth #2525 to show its range of patient-friendly drug delivery solutions, which can accommodate any formulation for subcutaneous and intramuscular injection: low viscosity, high viscosity, high volume, unstable, and more.

Increasing Disease Awareness to Contribute to the Growth of the Global Rheumatoid Arthritis Treatment Market : Persistence Market Research

Arthritis is a problem associated with joints, in which a person suffers from red, hot, swollen and functionally impaired joints.

Vertellus Presents ZeMac® Link NP at NPE

A new and patent-pending additive technology developed by Vertellus allows compounders and moulders to reduce costs and boost sustainability efforts while integrating previously incompatible materials into their alloys.

Vertellus Introduces ZeMac® Extend P at NPE

Vertellus is introducing ZeMac® Extend P, a chain extender additive that facilitates upgrading of recycled polyesters such as polyethylene terephthalate (PET) for use in a variety of target applications.